Oral Answers to Questions

Debate between Sara Britcliffe and Wendy Morton

Tuesday 26th October 2021 Commons Chamber

[Sara Britcliffe (Hyndburn) (Con)]

T5. Does my right hon. Friend the Secretary of State welcome the new agreement signed recently with Greece? Can she give examples of how the UK and Greece are working in greater

[Wendy Morton]

I was delighted that yesterday the Foreign Secretary met the Greek Foreign Minister, Minister Dendias, and signed a new strategic bilateral framework that will build on the co-operation between our countries. It will open up new opportunities for trade and investment in both countries, allowing us to build on the £4.5 billion-worth of annual trade that we already have. It will also enable better co-operation among our businesses, investors and industry, and will promote even stronger security and defence co-operation, both as NATO allies and in enhancing Europe’s resilience in the face of security threats.

Oral Answers to Questions

Debate between Sara Britcliffe and Wendy Morton

Tuesday 24th November 2020 Commons Chamber

[Sara Britcliffe (Hyndburn) (Con)]

What diplomatic steps the Government are taking to support the development of a covid-19 vaccine (a) in the UK and (b) throughout the world.

[The Parliamentary Under-Secretary of State for Foreign, Commonwealth and Development Affairs (Wendy Morton)]

The UK is committed to rapid, equitable access to safe and effective vaccines through multilateral collaboration. We strongly support the COVAX advance market commitment, which is the international initiative to support global equitable access. The UK is the largest bilateral donor to the AMC, having committed up to £548 million to help provide vaccines for up to 92 developing countries. The UK also committed £71 million in non-official development assistance to participate in the COVAX facility for self-financing countries, in order to secure options to vaccines for UK domestic use.

[Wendy Morton]

A pandemic response is absolutely what we need to tackle this virus, and that requires global collaboration. The UK strongly supports multilateral approaches so that we can meet both domestic and global needs, and that work goes alongside UK deals with individual vaccine developers. I am sure that, like me, the hon. Lady will welcome AstraZeneca’s commitment to non-profitable access during the pandemic and the fact that AstraZeneca estimates that up to 3 billion doses will be available globally by 2021.

[Sara Britcliffe]

My question follows on from that asked by the hon. Member for Wallasey (Ms Eagle). What specific steps is my hon. Friend the Minister taking to ensure that the UK is at the forefront of providing vaccines to vulnerable countries around the world?

[Wendy Morton]

I know how interested so many Members are in the access to and distribution of these incredibly important vaccines as part of our covid-19 response. Our £250 million of funding for the Coalition for Epidemic Preparedness Innovations is helping to develop vaccine candidates that can be scaled up and accessible for developing countries. Our commitment of up to £548 million to the COVAX AMC will contribute to the target of supplying 1 billion doses for 92 developing countries in 2021 and vaccinations for up to 500 million people. We have also worked with the World Bank to secure up to $12 billion in financing to support developing countries’ access to covid-19 vaccines, treatments and tests.